During the past decade, Hauptstrasse 240 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hauptstrasse 240" are "Tick-borne Encephalitis" (3 trials), "Encephalitis, Tick-borne" (2 trials), "Encephalitis, Tick-Borne" (1 trials) and "Tick Borne Encephalitis (TBE)" (1 trials). Many other conditions were trialed in "Hauptstrasse 240" in a lesser frequency.

Most popular intervention types in "Hauptstrasse 240" are "Biological" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)" (3 trials), "FSME-IMMUN NEW 0.25 ml" (1 trials), "Serology blood draw" (1 trials), "Tick-borne Encephalitis Vaccine" (1 trials) and "Tick-borne encephalitis vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hauptstrasse 240" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hauptstrasse 240". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hauptstrasse 240, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hauptstrasse 240, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".